Live Trading News
Latest News

The COVID Plandemic

By Paul Ebeling1 min read

#COVID #Fauci #plandemic

"In 2002, Ralph Baric, PhD. and colleagues at the University of North Carolina, Chapel Hill, filed a patent on recombinant coronavirus, and within a year, we got the world’s first SARS outbreak"--Paul Ebeling

FACTS:

  • In the early 2000s, David Martin, PhD., founder of M-CAM International, started finding large numbers of patents that violate biological and chemical weapons laws

  • In Y 1999, Dr. Anthony Fauci funded research to create “an infectious replication-defective recombinant coronavirus.” In 2002, Ralph Baric, PhD. and colleagues at the University of North Carolina, Chapel Hill, filed a patent on recombinant coronavirus, and within a year, we got the world’s first SARS outbreak

  • Since Y 1999, at least 4,000 patents involving coronavirus have been filed, including patents detailing Key features of the so-called “novel” SARS-CoV-2 virus

  • The Y 2001 anthrax attack, which came out of medical and defense research, led to the passage of the PREP Act, which removed liability for manufacturers of emergency medical countermeasures

  • The funds for entitlement programs and pensions will dry up by Y 2028, at which point the drug industry will go bankrupt as well. With a growing population that is ill from the COVID vaccinations and boosters, we need to prepare new systems to care for each other

For the skinny on Dr. Fauci read Robert F. Kennedy Jr.’s book “The Real Tony Fauci,” which details how his promotion of AZT during the 1980s ended up killing hundreds of thousands of people. And the pattern we see with coronavirus is a repeat of previous bad behavior.

There are serious consequences for bad behavior.

Have a healthy, happy weekend, Keep the Faith!

Advertisement
Target150
Keep reading
Read Live Trading News on Telegram

Every story, signed and delivered.

Subscribe to the kxco channel and get the headline, the AI-written key takeaways, and the chain-anchor link the moment we publish. Audio versions and per-ticker subscriptions arrive in the next iteration.

Open @KnightsbridgeInsightsNo email required.